The level of mRNA was correlated with BCL2 amplification, or a lack of methylation in BCL2 non-amplified SCLC cell lines (where high BCL-2 leads to greater sensitivity to venetoclax, and ultimately apoptosis) (Figure 1). The gene discussed is BCL2; the disease is small cell lung carcinoma.